Figure 3

(A) Number of genes gained or lost per case, stratified by BRCA status, (B) disease-specific survival stratified by volume of copy number changes per case (0–4=low, >4–16=intermediate, >16=high), (C) unsupervised cluster analysis of MBCs showing a loss predominant cluster (cluster A) and gain predominant cluster (cluster B) and ( D ) disease-specific survival of cluster A vs B.